Related Experiment Video
Updated: Jun 12, 2026
08:50
Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Relationship between renal function and heart failure in hypertensive patients
M Luque1, B de Rivas, J A Divisón
1Hypertension Unit, Hospital Clínico San Carlos, Universidad Complutense, Spain.
Internal Medicine Journal
|June 22, 2010
Summary
Hypertension and Heart Failure in Primary Care (HICAP) study found that diagnosed renal dysfunction increases heart failure risk in hypertensive patients. Renal function evaluation can identify high-risk individuals for early intervention.
Area of Science:
- Cardiology
- Nephrology
- Primary Care Medicine
Background:
- Hypertension is a major risk factor for heart failure (HF).
- Early identification of HF risk in hypertensive patients is crucial for timely intervention.
- The role of renal dysfunction in HF development among hypertensive individuals requires further elucidation in primary care settings.
Purpose of the Study:
- To investigate the association between diagnosed renal dysfunction and the risk of developing heart failure (HF) in hypertensive patients.
- To evaluate the utility of renal function assessment in identifying hypertensive patients at high risk for HF.
Main Methods:
- Cross-sectional, multicentre epidemiological study design.
- Conducted in primary care centers across Spain.
- Involved analysis of hypertensive patients without diagnosed heart failure.
Main Results:
- Diagnosed renal dysfunction was significantly associated with an increased risk of developing heart failure (HF) in hypertensive patients.
- Renal function evaluation using the Modification of Diet in Renal Disease (MDRD) formula demonstrated potential utility.
Conclusions:
- Renal dysfunction is a key factor associated with heart failure development in hypertensive patients.
- MDRD formula-based renal function assessment can aid in detecting high-risk hypertensive patients for HF prevention strategies.
Related Concept Videos
01:22Heart Failure Drugs: Diuretics
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
01:27Heart Failure I: Introduction
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
01:17Pathophysiology of Heart Failure
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
01:29Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
01:22Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.